PT1294739E - Compostos esteroides 16, 17-carbociclicos condensados possuindo actividade estrogenica selectiva - Google Patents
Compostos esteroides 16, 17-carbociclicos condensados possuindo actividade estrogenica selectivaInfo
- Publication number
- PT1294739E PT1294739E PT01931676T PT01931676T PT1294739E PT 1294739 E PT1294739 E PT 1294739E PT 01931676 T PT01931676 T PT 01931676T PT 01931676 T PT01931676 T PT 01931676T PT 1294739 E PT1294739 E PT 1294739E
- Authority
- PT
- Portugal
- Prior art keywords
- alkenyl
- alkyl
- alkynyl
- group
- mdash
- Prior art date
Links
- 230000001076 estrogenic effect Effects 0.000 title 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Substances 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 150000003431 steroids Chemical group 0.000 abstract 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 abstract 1
- 125000001118 alkylidene group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 102000015694 estrogen receptors Human genes 0.000 abstract 1
- 108010038795 estrogen receptors Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- -1 steroid compound Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00201986 | 2000-06-06 | ||
| PCT/EP2001/004868 WO2002000682A1 (en) | 2000-06-06 | 2001-05-01 | 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1294739E true PT1294739E (pt) | 2005-06-30 |
Family
ID=8171601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01931676T PT1294739E (pt) | 2000-06-06 | 2001-05-01 | Compostos esteroides 16, 17-carbociclicos condensados possuindo actividade estrogenica selectiva |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US7868193B2 (enExample) |
| EP (1) | EP1294739B1 (enExample) |
| JP (1) | JP5095902B2 (enExample) |
| KR (1) | KR100769865B1 (enExample) |
| CN (1) | CN1235908C (enExample) |
| AR (1) | AR028080A1 (enExample) |
| AT (1) | ATE293124T1 (enExample) |
| AU (2) | AU5838601A (enExample) |
| BR (1) | BR0111445A (enExample) |
| CA (1) | CA2410220C (enExample) |
| CZ (1) | CZ20024014A3 (enExample) |
| DE (1) | DE60110069T2 (enExample) |
| DK (1) | DK1294739T3 (enExample) |
| ES (1) | ES2240454T3 (enExample) |
| HU (1) | HUP0301190A3 (enExample) |
| IL (1) | IL152957A0 (enExample) |
| MX (1) | MXPA02012117A (enExample) |
| NO (1) | NO324247B1 (enExample) |
| PE (1) | PE20020214A1 (enExample) |
| PL (1) | PL203732B1 (enExample) |
| PT (1) | PT1294739E (enExample) |
| RU (1) | RU2255090C2 (enExample) |
| SK (1) | SK286852B6 (enExample) |
| TW (1) | TWI225068B (enExample) |
| WO (1) | WO2002000682A1 (enExample) |
| ZA (1) | ZA200209452B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8367648B2 (en) | 2009-06-10 | 2013-02-05 | Msd Oss B.V. | Substituted 16,17-annellated steroid compounds for use in womens healthcare |
| TW201109346A (en) * | 2009-06-10 | 2011-03-16 | Organon Nv | Substituted 16,17-annellated steroid compounds for use in women's healthcare |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194821A (en) * | 1963-12-30 | 1965-07-13 | Abbott Lab | 17alpha-substituted 17beta-hydroxyestrenes |
| CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
| IL123195A (en) * | 1997-02-21 | 2002-11-10 | Akzo Nobel Nv | Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them |
-
2001
- 2001-04-17 TW TW090109186A patent/TWI225068B/zh not_active IP Right Cessation
- 2001-05-01 IL IL15295701A patent/IL152957A0/xx not_active IP Right Cessation
- 2001-05-01 EP EP01931676A patent/EP1294739B1/en not_active Expired - Lifetime
- 2001-05-01 RU RU2002135594/04A patent/RU2255090C2/ru not_active IP Right Cessation
- 2001-05-01 WO PCT/EP2001/004868 patent/WO2002000682A1/en not_active Ceased
- 2001-05-01 PL PL359238A patent/PL203732B1/pl not_active IP Right Cessation
- 2001-05-01 DK DK01931676T patent/DK1294739T3/da active
- 2001-05-01 US US10/297,706 patent/US7868193B2/en not_active Expired - Fee Related
- 2001-05-01 ES ES01931676T patent/ES2240454T3/es not_active Expired - Lifetime
- 2001-05-01 AT AT01931676T patent/ATE293124T1/de active
- 2001-05-01 BR BR0111445-0A patent/BR0111445A/pt not_active IP Right Cessation
- 2001-05-01 JP JP2002505804A patent/JP5095902B2/ja not_active Expired - Fee Related
- 2001-05-01 CZ CZ20024014A patent/CZ20024014A3/cs unknown
- 2001-05-01 AU AU5838601A patent/AU5838601A/xx active Pending
- 2001-05-01 AU AU2001258386A patent/AU2001258386B2/en not_active Ceased
- 2001-05-01 KR KR1020027016657A patent/KR100769865B1/ko not_active Expired - Fee Related
- 2001-05-01 MX MXPA02012117A patent/MXPA02012117A/es active IP Right Grant
- 2001-05-01 PT PT01931676T patent/PT1294739E/pt unknown
- 2001-05-01 HU HU0301190A patent/HUP0301190A3/hu unknown
- 2001-05-01 SK SK1707-2002A patent/SK286852B6/sk not_active IP Right Cessation
- 2001-05-01 CN CNB018107451A patent/CN1235908C/zh not_active Expired - Fee Related
- 2001-05-01 CA CA002410220A patent/CA2410220C/en not_active Expired - Fee Related
- 2001-05-01 DE DE60110069T patent/DE60110069T2/de not_active Expired - Lifetime
- 2001-05-03 PE PE2001000401A patent/PE20020214A1/es not_active Application Discontinuation
- 2001-05-04 AR ARP010102107A patent/AR028080A1/es unknown
-
2002
- 2002-11-20 ZA ZA200209452A patent/ZA200209452B/en unknown
- 2002-12-02 NO NO20025793A patent/NO324247B1/no not_active IP Right Cessation
-
2010
- 2010-06-15 US US12/816,058 patent/US20100249083A1/en not_active Abandoned
-
2011
- 2011-05-20 US US13/112,184 patent/US20110224183A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2179273T3 (es) | N-bencil-2-fenilindolas como agentes estrogenicos. | |
| PT1178045E (pt) | Derivados de azaindole-etilamina como agentes de ligacao de receptores de acetilcolina nicotinicos | |
| TR200002774T2 (tr) | Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri | |
| ES2145915T3 (es) | Derivados estereoquimicos de la wortmannina. | |
| ES2162198T3 (es) | Agentes estrogenos. | |
| DK0582338T3 (da) | 17-spiromethylensteroider | |
| DE69523622D1 (de) | Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene | |
| ES2155566T3 (es) | Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia. | |
| AR005672A1 (es) | Derivados de la distamicina, proceso para prepararlos, y su utilizacion como agentes antitumorales y antivirales. | |
| ES2110260T3 (es) | Androstenonas. | |
| ES2151168T3 (es) | N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| DE69841374D1 (de) | 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase | |
| GB0227655D0 (en) | Use | |
| CO4230021A1 (es) | Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos. | |
| BG105710A (en) | 5ht1 antagonists for antidepressant therapy | |
| PT1294739E (pt) | Compostos esteroides 16, 17-carbociclicos condensados possuindo actividade estrogenica selectiva | |
| ES2164400T3 (es) | Esteroides con actividad anticonceptiva y antiosteoporotica. | |
| DK0988312T3 (da) | 17beta-allyloxy(thio)alkyl-androstanderivater til modulering af meiose | |
| BR0013769A (pt) | Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide | |
| UA41350C2 (uk) | Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі | |
| BG103271A (en) | Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means | |
| FI932446A0 (fi) | 2b,19-metylaminobrosteroider som aromatasinhibitorer | |
| ATE73136T1 (de) | Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate. | |
| DK1196428T3 (da) | 11-beta-aryl-17,17-spirothiolan-substituerede steroider | |
| ECSP014057A (es) | Compuestos esteroides para la modificacion selectiva de la actividad de los receptores de estrogenos |